Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications Anvarsadat KianmehrIsabella FaraoniAbdolkarim Mahrooz Review 03 May 2021 Pages: 1587 - 1598
Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study Chuanfeng ZhangMengjiao CaoLinfu Zhou Original Article 01 March 2021 Pages: 1599 - 1608
Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing Christine C. GinocchioCarolina Garcia-Mondragonand the EME Evaluation Program Collaborative Original Article Open access 02 March 2021 Pages: 1609 - 1622
Therapeutic efficacy of chitosan nanoparticles loaded with BCG-polysaccharide nucleic acid and ovalbumin on airway inflammation in asthmatic mice Wentao YangZhaohui DongYanping Xie Original Article 05 March 2021 Pages: 1623 - 1631
Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019 Liang ChenXiudi HanXiqian Xing Original Article 06 March 2021 Pages: 1633 - 1643
Incidence, clinical characteristics, risk factors and outcomes of meningoencephalitis in patients with COVID-19 Marcos FragielÒscar Miróon behalf of the Spanish Investigators on Emergency Situations TeAm (SIESTA) network Original Article 09 March 2021 Pages: 1645 - 1656
Short time to blood culture positivity in Enterococcus faecalis infective endocarditis Karl OldbergRebecca ThorénMagnus Rasmussen Original Article Open access 09 March 2021 Pages: 1657 - 1664
Bloodstream infections in older population: epidemiology, outcome, and impact of multidrug resistance Marine de LarocheLesly FellousAurélien Dinh Original Article 10 March 2021 Pages: 1665 - 1672
Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis Nicolas MassartGuilhem WattecampsPierre Fillatre Original Article 10 March 2021 Pages: 1673 - 1680
Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence Lívia Custódio PereiraAmabel Fernandes CorreiaYanna Karla de Medeiros Nóbrega Original Article Open access 13 March 2021 Pages: 1681 - 1693
Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples Daniëlle A. T. HanssenMichiel SlaatsInge H. M. van Loo Original Article Open access 17 March 2021 Pages: 1695 - 1703
Evaluation of the CARDS toxin and its fragment for the serodiagnosis of Mycoplasma pneumoniae infections Guanhua XueHanqing ZhaoJing Yuan Original Article 18 March 2021 Pages: 1705 - 1711
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran Mostafa Salehi-VaziriTahmineh JalaliAmitis Ramezani Original Article 18 March 2021 Pages: 1713 - 1719
Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19 William StokesByron M. BerengerGraham Tipples Original Article 20 March 2021 Pages: 1721 - 1726
Antimicrobial stewardship experience in paediatrics: first-year activity report Erika SilvestroRaffaella MarinoCarlo Scolfaro Original Article 20 March 2021 Pages: 1727 - 1735
Changes in antimicrobial resistance and outcomes of health care–associated infections Mehtap AydınEmel AzakÖnder Ergönül Brief Report 14 February 2021 Pages: 1737 - 1742
Evaluation of a novel rapid TRC assay for the detection of influenza using nasopharyngeal swabs and gargle samples Norihito KakuKohji HashiguchiKatsunori Yanagihara Brief Report 16 February 2021 Pages: 1743 - 1748
Evaluation of two rapid phenotypical tests—Alifax rapid AST colistin test and Rapid Polymyxin NP test—for detection of colistin resistance in Enterobacterales Julija GermKatja SemeMateja Pirs Brief Report Open access 17 February 2021 Pages: 1749 - 1753
Ceftazidime-avibactam, meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam against multidrug-resistant, metallo-β-lactamase-producing Klebsiella pneumoniae Sofia MarakiViktoria Eirini MavromanolakiEffie Scoulica Brief Report 17 February 2021 Pages: 1755 - 1759
KPC-12 with a L169M substitution in the Ω loop has reduced carbapenemase activity Jiayuan QinYu FengZhiyong Zong Brief Report 17 February 2021 Pages: 1761 - 1766
Stepwise selection of mutation conferring fluroquinolone resistance: multisite MDR-TB cohort study Jingtao GaoJian DuYu Pang Brief Report 18 February 2021 Pages: 1767 - 1771
Temocillin as an alternative treatment for acute bacterial cholangitis: a retrospective microbiology susceptibility-based study of 140 episodes Sylvain ChawkiAurélien SokalVictoire de Lastours Brief Report 20 February 2021 Pages: 1773 - 1777
Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar Fatma Ben AbidClement K. M. TsuiAli S. Omrani Brief Report Open access 22 February 2021 Pages: 1779 - 1785
Annual variations of Haemophilus influenzae carriage among Hajj pilgrims Van-Thuan HoangThi-Loi DaoPhilippe Gautret Letter to the Editor 28 May 2021 Pages: 1787 - 1788
Correction to: An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy Sahand ImaniHergen BuscherIndy Sandaradura Correction 17 June 2021 Pages: 1789 - 1789
